Quadrant Capital Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-573
| Closed | -$23.2K | – | 1366 |
|
|
2025
Q1 | $23.2K | Hold |
573
| – | – | ﹤0.01% | 1995 |
|
|
2024
Q4 | $15.9K | Hold |
573
| – | – | ﹤0.01% | 1981 |
|
|
2024
Q3 | $16.4K | Hold |
573
| – | – | ﹤0.01% | 1975 |
|
|
2024
Q2 | $13.4K | Sell |
573
-146
| -20% | -$3.43K | ﹤0.01% | 2016 |
|
|
2024
Q1 | $18.2K | Buy |
719
+93
| +15% | +$2.35K | ﹤0.01% | 1889 |
|
|
2023
Q4 | $14.6K | Buy |
626
+15
| +2% | +$350 | ﹤0.01% | 1927 |
|
|
2023
Q3 | $30.9K | Hold |
611
| – | – | ﹤0.01% | 1500 |
|
|
2023
Q2 | $28.5K | Hold |
611
| – | – | ﹤0.01% | 1538 |
|
|
2023
Q1 | $23.4K | Sell |
611
-85
| -12% | -$3.25K | ﹤0.01% | 1620 |
|
|
2022
Q4 | $38.1K | Buy |
696
+28
| +4% | +$1.53K | ﹤0.01% | 1335 |
|
|
2022
Q3 | $23K | Buy |
668
+111
| +20% | +$3.82K | ﹤0.01% | 1461 |
|
|
2022
Q2 | $5K | Buy |
+557
| New | +$5K | ﹤0.01% | 1934 |
|